JP2009534405A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534405A5
JP2009534405A5 JP2009506741A JP2009506741A JP2009534405A5 JP 2009534405 A5 JP2009534405 A5 JP 2009534405A5 JP 2009506741 A JP2009506741 A JP 2009506741A JP 2009506741 A JP2009506741 A JP 2009506741A JP 2009534405 A5 JP2009534405 A5 JP 2009534405A5
Authority
JP
Japan
Prior art keywords
alkyl
och
nhch
coch
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009506741A
Other languages
English (en)
Japanese (ja)
Other versions
JP5331679B2 (ja
JP2009534405A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/066868 external-priority patent/WO2007124319A1/en
Publication of JP2009534405A publication Critical patent/JP2009534405A/ja
Publication of JP2009534405A5 publication Critical patent/JP2009534405A5/ja
Application granted granted Critical
Publication of JP5331679B2 publication Critical patent/JP5331679B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009506741A 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤 Expired - Fee Related JP5331679B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79366706P 2006-04-20 2006-04-20
US60/793,667 2006-04-20
PCT/US2007/066868 WO2007124319A1 (en) 2006-04-20 2007-04-18 Inhibitors of c-fms kinase

Publications (3)

Publication Number Publication Date
JP2009534405A JP2009534405A (ja) 2009-09-24
JP2009534405A5 true JP2009534405A5 (enExample) 2010-05-13
JP5331679B2 JP5331679B2 (ja) 2013-10-30

Family

ID=38472852

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009506744A Expired - Fee Related JP5331681B2 (ja) 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤
JP2009506741A Expired - Fee Related JP5331679B2 (ja) 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤
JP2009506742A Expired - Fee Related JP5331680B2 (ja) 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009506744A Expired - Fee Related JP5331681B2 (ja) 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009506742A Expired - Fee Related JP5331680B2 (ja) 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤

Country Status (22)

Country Link
US (7) US8722718B2 (enExample)
EP (3) EP2016070B1 (enExample)
JP (3) JP5331681B2 (enExample)
KR (3) KR101491564B1 (enExample)
CN (1) CN101472914B (enExample)
AR (3) AR060611A1 (enExample)
AU (3) AU2007240442B2 (enExample)
BR (1) BRPI0710548B8 (enExample)
CA (3) CA2649924C (enExample)
ES (3) ES2565238T3 (enExample)
IL (1) IL194845A (enExample)
MX (3) MX2008013531A (enExample)
NO (1) NO20084896L (enExample)
NZ (3) NZ572070A (enExample)
PE (1) PE20080074A1 (enExample)
RU (1) RU2475483C2 (enExample)
SG (1) SG171593A1 (enExample)
TW (3) TW200815415A (enExample)
UA (1) UA93085C2 (enExample)
UY (1) UY30297A1 (enExample)
WO (3) WO2007124319A1 (enExample)
ZA (1) ZA200809873B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060281788A1 (en) * 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
JP5580535B2 (ja) * 2006-01-05 2014-08-27 ノバルティス アーゲー 癌転移および癌転移に関連する骨量減少を予防および処置するための方法
WO2007124316A1 (en) 2006-04-20 2007-11-01 Janssen Pharmaceutica N.V. Heterocyclic compounds as inhibitors of c-fms kinase
MX2008013531A (es) 2006-04-20 2009-01-20 Janssen Pharmaceutica Nv Inhibidores de c-fms cinasa.
EP2397138B1 (en) * 2006-04-20 2013-12-11 Janssen Pharmaceutica NV Aromatic amide derivatives as C-KIT kinase inhibitors
US8697716B2 (en) 2006-04-20 2014-04-15 Janssen Pharmaceutica Nv Method of inhibiting C-KIT kinase
CA2649919C (en) * 2006-04-20 2019-06-18 Janssen Pharmaceutica N.V. Phenyl-or pyridinyl amides as inhibitors of protein tyrosine kinases
JO3240B1 (ar) * 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
US10106798B2 (en) 2010-01-05 2018-10-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) FLT3 receptor antagonists for the treatment or the prevention of pain disorders
WO2011083124A1 (en) * 2010-01-05 2011-07-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Flt3 receptor antagonists for the treatment or the prevention of pain disorders
CN103501785B (zh) 2011-05-05 2016-10-26 诺瓦提斯公司 用于治疗脑肿瘤的csf-1r抑制剂
US8940742B2 (en) * 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP2882757B1 (en) 2012-08-07 2016-10-05 Janssen Pharmaceutica, N.V. Process for the preparation of heterocyclic ester derivatives
CN104520295B (zh) 2012-08-07 2017-07-18 詹森药业有限公司 用于制备c‑fms激酶抑制剂的方法
MX389256B (es) 2013-10-04 2025-03-20 Infinity Pharmaceuticals Inc Compuestos heterociclicos y usos de los mismos.
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
SI3102576T1 (sl) * 2014-02-03 2019-08-30 Vitae Pharmaceuticals, Llc Inhibitorji dihidropirolopiridina ROR-gama
EP4066834A1 (en) 2014-03-19 2022-10-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN108349985A (zh) 2015-09-14 2018-07-31 无限药品股份有限公司 异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2021144360A1 (en) 2020-01-17 2021-07-22 F. Hoffmann-La Roche Ag Small molecule csf-1r inhibitors in therapeutic and cosmetic uses
CN112441941B (zh) * 2020-12-03 2022-08-02 浙江荣耀生物科技股份有限公司 一种1-(4-氨基苯基)环戊基甲腈的制备方法

Family Cites Families (138)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2466420A (en) 1947-11-26 1949-04-05 Eastman Kodak Co Ketene condensation products with aldehydes
US3226394A (en) 1964-06-16 1965-12-28 Shulton Inc Pyridylethylated anthranilamides and derivatives thereof
CH504416A (de) 1966-12-05 1971-03-15 Ciba Geigy Ag Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
US4551540A (en) 1983-01-17 1985-11-05 Borg-Warner Chemicals, Inc. Substituted 2,5-dimethylpyrroles
JPH0264704A (ja) 1988-08-30 1990-03-05 Honda Motor Co Ltd 自動化設備の制御システム
EP0358459B1 (en) * 1988-09-08 1996-06-19 Sony Corporation Picture processing apparatus
JPH0299250A (ja) 1988-09-30 1990-04-11 Kobe Steel Ltd タンディッシュのスラグ除去方法
JP2833106B2 (ja) 1990-02-21 1998-12-09 株式会社島津製作所 液体クロマトグラフ
JPH03255915A (ja) 1990-03-07 1991-11-14 Nkk Corp 流量検出装置
US5190541A (en) * 1990-10-17 1993-03-02 Boston Scientific Corporation Surgical instrument and method
JPH04184937A (ja) 1990-11-20 1992-07-01 Oki Electric Ind Co Ltd 半導体集積回路装置の製造方法
JPH04212503A (ja) 1990-12-05 1992-08-04 Mitsubishi Electric Corp トリプレート線路共振器
JPH0821207B2 (ja) 1992-02-03 1996-03-04 日本コロムビア株式会社 ディスク装置
EP0627940B1 (en) * 1992-03-05 2003-05-07 Board of Regents, The University of Texas System Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
US5474765A (en) * 1992-03-23 1995-12-12 Ut Sw Medical Ctr At Dallas Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
JPH05293265A (ja) 1992-04-17 1993-11-09 Juki Corp 千鳥縫いミシンの針振り駆動変更装置
JPH0815587B2 (ja) 1992-05-01 1996-02-21 東亜工業株式会社 振動ふるい
JPH05346639A (ja) 1992-06-15 1993-12-27 Konica Corp 写真処理廃液の再利用方法
JPH0684710A (ja) 1992-09-03 1994-03-25 Matsushita Electric Ind Co Ltd 電解コンデンサ
US5686472A (en) 1992-10-29 1997-11-11 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
KR100360206B1 (ko) * 1992-12-10 2003-02-11 소니 가부시끼 가이샤 화상신호변환장치
JP3243861B2 (ja) 1992-12-10 2002-01-07 ソニー株式会社 画像情報変換装置
JPH06189231A (ja) 1992-12-16 1994-07-08 Toshiba Corp 液晶表示装置
JP3522818B2 (ja) 1993-02-26 2004-04-26 富士写真フイルム株式会社 写真用支持体
US5593992A (en) 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
JP3192537B2 (ja) 1993-11-18 2001-07-30 キヤノン株式会社 走査光学装置
JP3197737B2 (ja) 1994-02-15 2001-08-13 三洋電機株式会社 コインメカニズムの取付け装置
JPH07310319A (ja) 1994-05-19 1995-11-28 Katsuyuki Hasegawa 杭打ち装置及び杭打ちアタッチメント
JP3592748B2 (ja) 1994-07-01 2004-11-24 三菱重工業株式会社 蒸気、ガスタービン複合プラントの廃熱による蒸気生成システム
JPH08107715A (ja) 1994-10-13 1996-04-30 Iseki & Co Ltd コンバインの拡縮式グレンタンク装置
WO1996011932A1 (en) 1994-10-14 1996-04-25 Smithkline Beecham Plc 2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials
JP3357754B2 (ja) 1994-10-18 2002-12-16 三洋電機株式会社 疑似ステレオ画像生成方法及び疑似ステレオ画像生成装置
JPH08287118A (ja) 1995-02-16 1996-11-01 Fujitsu Ltd 部品標準化方式
JPH07322944A (ja) 1995-04-10 1995-12-12 Sanyo Electric Co Ltd 透視板
CA2216943C (en) 1995-04-19 2003-06-17 Boston Scientific Limited Drug release coated stent
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
JP3415333B2 (ja) 1995-07-13 2003-06-09 トヨタ自動車株式会社 水素吸蔵合金
TW349948B (en) 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
GB9523675D0 (en) * 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
SK283335B6 (sk) * 1995-12-08 2003-06-03 Janssen Pharmaceutica N. V. (Imidazol-5-yl)metyl-2-chinolinónové deriváty, spôsob a medziprodukty na ich prípravu, ich použitie a farmaceutické kompozície na ich báze
US5874442A (en) 1995-12-22 1999-02-23 Schering-Plough Corporation Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
US6011029A (en) 1996-02-26 2000-01-04 Bristol-Myers Squibb Company Inhibitors of farnesyl protein transferase
US5702390A (en) * 1996-03-12 1997-12-30 Ethicon Endo-Surgery, Inc. Bioplar cutting and coagulation instrument
AU711936B2 (en) 1996-08-09 1999-10-28 Banyu Pharmaceutical Co., Ltd. Stereoselective deoxygenation reaction
JP2001505548A (ja) 1996-12-20 2001-04-24 トヴァリシェストヴォ エス オグラニチェンノイ オトヴェトストヴェンノストジュ“タブジュファーム” 凍結乾燥ハイドロクロライド−1β,10β−エポキシ−13−ジメチルアミノ−グアヤ−3(4)−エン−6,12−オリドの生成方法および装置
UA59384C2 (uk) 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
TW591030B (en) 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
EP0977750B1 (en) 1997-04-25 2007-07-04 Janssen Pharmaceutica N.V. Farnesyltransferase inhibiting quinazolinones
TW491872B (en) 1997-05-27 2002-06-21 Ciba Sc Holding Ag Block oligomers containing l-hydrocarbyloxy-2,2,6,6-tetramethyl-4- piperidyl groups as stabilizers for lower polyolefin
US6100254A (en) * 1997-10-10 2000-08-08 Board Of Regents, The University Of Texas System Inhibitors of protein tyrosine kinases
PT1060619E (pt) 1998-03-05 2002-11-29 Formula One Administration Ltd Sistema de comunicacao de dados
US6303654B1 (en) 1998-03-12 2001-10-16 Wisconsin Alumni Research Foundation Acyclic monoterpenoid derivatives
WO2000001691A1 (en) 1998-07-01 2000-01-13 Merck & Co., Inc. Process for making farnesyl-protein transferase inhibitors
WO2000002871A1 (en) 1998-07-10 2000-01-20 Merck & Co., Inc. Novel angiogenesis inhibitors
US6284098B1 (en) * 1998-07-20 2001-09-04 Wwj, Llc Lignocellulose fiber filler for thermoplastic composite compositions
AP2001002079A0 (en) 1998-08-27 2001-03-31 Pfizer Prod Inc Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents.
CA2341739C (en) 1998-08-27 2005-07-12 Pfizer Products Inc. Quinolin-2-one derivatives useful as anticancer agents
GB9824579D0 (en) 1998-11-10 1999-01-06 Novartis Ag Organic compounds
CZ302374B6 (cs) 1998-12-23 2011-04-20 Janssen Pharmaceutica N.V. Derivát 1,2-anelovaného chinolinu, zpusob a meziprodukt pro jeho prípravu a farmaceutický prostredek s jeho obsahem
AU779008C (en) 1999-01-11 2005-06-30 Princeton University High affinity inhibitors for target validation and uses thereof
PT1169038E (pt) 1999-04-15 2012-10-26 Bristol Myers Squibb Co Inibidores cíclicos da proteína tirosina cinase
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
ES2223705T3 (es) 1999-04-28 2005-03-01 Board Of Regents, The University Of Texas System Composiciones y metodos para el tratamiento de cancer mediante inhibi cion selectiva del vegf.
JP3766231B2 (ja) 1999-05-10 2006-04-12 Necビューテクノロジー株式会社 液晶表示装置
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
KR100652100B1 (ko) * 1999-08-05 2006-12-01 산요덴키가부시키가이샤 화상 보간 방법
JP2001078113A (ja) 1999-09-06 2001-03-23 Sony Corp 映像機器および映像表示方法
US6852752B2 (en) 1999-12-17 2005-02-08 Vicuron Pharmaceuticals Inc. Urea compounds, compositions and methods of use and preparation
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
EP1246823A1 (en) 1999-12-28 2002-10-09 Pharmacopeia, Inc. Pyrimidine and triazine kinase inhibitors
FR2803592A1 (fr) * 2000-01-06 2001-07-13 Aventis Cropscience Sa Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
GB0005357D0 (en) * 2000-03-06 2000-04-26 Smithkline Beecham Plc Compounds
US6558385B1 (en) 2000-09-22 2003-05-06 Tissuelink Medical, Inc. Fluid-assisted medical device
US6692491B1 (en) 2000-03-24 2004-02-17 Scimed Life Systems, Inc. Surgical methods and apparatus for positioning a diagnostic or therapeutic element around one or more pulmonary veins or other body structures
US6776796B2 (en) 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
JP4150947B2 (ja) * 2000-08-23 2008-09-17 ソニー株式会社 画像処理装置および方法、並びに記録媒体
WO2002032861A2 (en) 2000-10-17 2002-04-25 Merck & Co., Inc. Orally active salts with tyrosine kinase activity
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
TWI238824B (en) 2001-05-14 2005-09-01 Novartis Ag 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
US7101884B2 (en) 2001-09-14 2006-09-05 Merck & Co., Inc. Tyrosine kinase inhibitors
WO2003024931A1 (en) 2001-09-14 2003-03-27 Merck & Co., Inc. Tyrosine kinase inhibitors
TWI259081B (en) 2001-10-26 2006-08-01 Sugen Inc Treatment of acute myeloid leukemia with indolinone compounds
CN101703509A (zh) 2001-10-30 2010-05-12 诺瓦提斯公司 作为flt3受体酪氨酸激酶活性抑制剂的星形孢菌素衍生物
EP1458713B1 (en) 2001-12-27 2005-08-24 Theravance, Inc. Indolinone derivatives useful as protein kinase inhibitors
JP4218249B2 (ja) 2002-03-07 2009-02-04 株式会社日立製作所 表示装置
NZ537155A (en) 2002-05-23 2006-09-29 Cytopia Pty Ltd Protein kinase inhibitors
AR037647A1 (es) 2002-05-29 2004-12-01 Novartis Ag Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
GB0215676D0 (en) 2002-07-05 2002-08-14 Novartis Ag Organic compounds
EP1546117A2 (en) 2002-08-14 2005-06-29 Vertex Pharmaceuticals Incorporated Protein kinase inhibitors and uses thereof
BR0313743A (pt) 2002-08-23 2005-07-05 Chiron Corp Benzimidazol quinolinonas e usos destas
AU2003258491A1 (en) * 2002-09-05 2004-03-29 Neurosearch A/S Amide derivatives and their use as chloride channel blockers
CA2500727A1 (en) * 2002-10-03 2004-04-15 Targegen, Inc. Vasculostatic agents and methods of use thereof
US20080207617A1 (en) 2002-10-29 2008-08-28 Kirin Beer Kabushiki Kaisha Quinoline Derivatives and Quinazoline Derivatives Inhibiting Autophosphrylation of Flt3 and Medicinal Compositions Containing the Same
MXPA05004754A (es) 2002-11-13 2005-08-02 Chiron Corp Metodos para tratar cancer y metodos relacionados.
TWI335913B (en) 2002-11-15 2011-01-11 Vertex Pharma Diaminotriazoles useful as inhibitors of protein kinases
ATE543488T1 (de) 2002-11-18 2012-02-15 Univ Rutgers Medizinische vorrichtungen, bei denen neuepolymere verwendet werden
BR0316722A (pt) 2002-11-19 2005-10-18 Univ Pennsylvania Constructos genéticos e composições compreendendo rre e cte e usos destes
WO2004058749A1 (en) 2002-12-18 2004-07-15 Vertex Pharmaceuticals Incorporated Benzisoxazole derivatives useful as inhibitors of protein kinases
WO2004089918A1 (ja) 2003-04-09 2004-10-21 Japan Tobacco Inc. 複素芳香5員環化合物及びその医薬用途
US7427683B2 (en) * 2003-04-25 2008-09-23 Ortho-Mcneil Pharmaceutical, Inc. c-fms kinase inhibitors
US7790724B2 (en) 2003-04-25 2010-09-07 Janssen Pharmaceutica N.V. c-fms kinase inhibitors
US7429603B2 (en) 2003-04-25 2008-09-30 3-Dimensional Pharmaceuticals, Inc. C-fms kinase inhibitors
US20050113566A1 (en) 2003-04-25 2005-05-26 Player Mark R. Inhibitors of C-FMS kinase
NZ545032A (en) 2003-07-28 2009-02-28 Smithkline Beecham Corp Cycloalkylidene compounds as modulators of estrogen receptor
EP1684750B1 (en) 2003-10-23 2010-04-28 AB Science 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
GB0326601D0 (en) 2003-11-14 2003-12-17 Novartis Ag Organic compounds
AU2005209485A1 (en) 2004-01-30 2005-08-11 Ab Science 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
JP4628770B2 (ja) * 2004-02-09 2011-02-09 株式会社日立製作所 照明装置を備えた画像表示装置及び画像表示方法
JP2006084710A (ja) 2004-09-15 2006-03-30 Toshiba Matsushita Display Technology Co Ltd 表示制御回路、表示制御方法、および液晶表示装置
US20060132383A1 (en) 2004-09-27 2006-06-22 Idc, Llc System and method for illuminating interferometric modulator display
US7645755B2 (en) 2004-10-22 2010-01-12 Janssen Pharmaceutical N.V. Inhibitors of c-fms kinase
NZ555289A (en) 2004-10-22 2010-10-29 Janssen Pharmaceutica Nv Inhibitors of c-fms kinase
MX2007004784A (es) 2004-10-22 2007-09-11 Johnson & Johnson Inhibidores de la c-fms cinasa.
DE602005015742D1 (de) 2004-10-22 2009-09-10 Janssen Pharmaceutica Nv Aromatische amide als hemmer der c-fms-kinase
JP4904783B2 (ja) 2005-03-24 2012-03-28 ソニー株式会社 表示装置及び表示方法
US20060281769A1 (en) 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
US20060281755A1 (en) 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
US20060281700A1 (en) 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
US20060281788A1 (en) 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
US20060281771A1 (en) 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators
CN101340909B (zh) 2005-10-18 2012-01-11 詹森药业有限公司 抑制flt3激酶的方法
TW200734327A (en) 2005-11-03 2007-09-16 Vertex Pharma Aminopyrimidines useful as kinase inhibitors
EP1951716B1 (en) * 2005-11-16 2011-05-04 Vertex Pharmaceuticals, Inc. Aminopyrimidines useful as kinase inhibitors
JP4950480B2 (ja) * 2005-11-22 2012-06-13 東芝モバイルディスプレイ株式会社 液晶表示装置
KR100815916B1 (ko) * 2006-02-09 2008-03-21 엘지.필립스 엘시디 주식회사 액정 표시장치의 구동장치 및 구동방법
MX2008013531A (es) * 2006-04-20 2009-01-20 Janssen Pharmaceutica Nv Inhibidores de c-fms cinasa.
WO2007124316A1 (en) * 2006-04-20 2007-11-01 Janssen Pharmaceutica N.V. Heterocyclic compounds as inhibitors of c-fms kinase
US8697716B2 (en) 2006-04-20 2014-04-15 Janssen Pharmaceutica Nv Method of inhibiting C-KIT kinase
CA2649919C (en) * 2006-04-20 2019-06-18 Janssen Pharmaceutica N.V. Phenyl-or pyridinyl amides as inhibitors of protein tyrosine kinases
JP2008096956A (ja) * 2006-09-15 2008-04-24 Olympus Corp 画像表示方法および画像表示装置
JP4479709B2 (ja) * 2006-10-27 2010-06-09 セイコーエプソン株式会社 画像表示装置、画像表示方法、画像表示プログラム、及び画像表示プログラムを記録した記録媒体、並びに電子機器
TWI354960B (en) * 2006-11-07 2011-12-21 Realtek Semiconductor Corp Method for controlling display device
JP4285532B2 (ja) 2006-12-01 2009-06-24 ソニー株式会社 バックライト制御装置、バックライト制御方法、および液晶表示装置
JP5117762B2 (ja) 2007-05-18 2013-01-16 株式会社半導体エネルギー研究所 液晶表示装置
JO3240B1 (ar) * 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
AU2008318656A1 (en) 2007-10-31 2009-05-07 Janssen Pharmaceutica N.V. Biomarker for assessing response to FMS treatment
WO2009157224A1 (ja) 2008-06-27 2009-12-30 シャープ株式会社 液晶表示装置の制御装置、液晶表示装置、液晶表示装置の制御方法、プログラムおよび記録媒体

Similar Documents

Publication Publication Date Title
JP2009534405A5 (enExample)
JP2009534406A5 (enExample)
JP2009534407A5 (enExample)
RU2008145763A (ru) Ингибиторы с-fmc киназы
JP2016520618A5 (enExample)
JP2015535832A5 (enExample)
JP2008515852A5 (enExample)
JP2013510825A5 (enExample)
PT1539753E (pt) Compostos de pirazolo(3,4-b)piridina e sua utilização como inibidores da fosfodiesterase
JP2008503515A5 (enExample)
JP2013523710A5 (enExample)
JP2018519323A5 (enExample)
EP2813509B1 (en) 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4,3-c]isoquinoline derivatives
JP2013532652A5 (enExample)
JP2009539848A5 (enExample)
JP2013523802A5 (enExample)
JP2011507878A5 (enExample)
JP2016514719A5 (enExample)
JP2010540593A5 (enExample)
JP2009534404A5 (enExample)
JP2012524055A5 (enExample)
JP2007516983A5 (enExample)
JP2012502067A5 (enExample)
JP2006528597A5 (enExample)
JP2009534403A5 (enExample)